Does Protagonist Therapeutics (PTGX) Pay a Dividend? (2026)
Short answer
Protagonist Therapeutics (PTGX) pays little or no dividend; like many growth-oriented companies it reinvests cash rather than paying income. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Protagonist Therapeutics (PTGX) pay a dividend?
Protagonist Therapeutics (PTGX) currently returns little or nothing as a dividend. As of June 2026, revenue was dominated by milestone and collaboration payments, including a ~$50M ICOTYDE approval milestone and a ~$200M rusfertide opt-out payment, which produced a small Q1 profit even though trailing-twelve-month results were still a net loss of roughly $115M. The ~$620M cash balance is expected to fund operations through at least 2028. Standard earnings multiples are not very meaningful here because income is lumpy and tied to one-time partner events rather than recurring product sales.
How to think about PTGX's dividend
- Yield is a snapshot: minimal today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like PTGX.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the PTGX dividend
Protagonist Therapeutics (PTGX) is not an income stock; if you own it, it is for growth or total return, not the dividend. For the full picture see the PTGX guide. Walnut can show how PTGX fits your real portfolio. It is not an investment adviser.
Build a basket around PTGX with Walnut
Use Protagonist Therapeutics as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Protagonist Therapeutics (PTGX) pay a dividend?
+
Protagonist Therapeutics (PTGX) pays little or no dividend; like many growth-stage companies it tends to reinvest cash rather than return it as income. Verify the current policy on PTGX's investor relations page.
What is PTGX's dividend yield?
+
PTGX's yield is minimal or zero. Companies prioritizing growth often pay no dividend and return cash through buybacks instead, if at all.
How often does PTGX pay its dividend?
+
US companies that pay dividends, like Protagonist Therapeutics if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on PTGX's investor relations page before relying on the timing.
Can I reinvest PTGX dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any PTGX dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is PTGX a good dividend stock?
+
Walnut is informational, not investment advice. PTGX is a growth or total-return name rather than an income stock. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with PTGX's investor relations page or your broker.